|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net loss | |||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||
| Depreciation and amortization expense | |||
| Stock-based compensation expense | |||
| Impairment of intangible asset | |||
| Change in fair value of contingent consideration | |||
| Deferred income tax benefit | |||
| Changes in operating assets and liabilities: | |||
| Collaboration receivables | |||
| Prepaid expenses and other assets | |||
| Right-of-use assets | |||
| Long-term prepaid rent | |||
| Accounts payable | |||
| Accrued expenses | |||
| Deferred rent | |||
| Lease liability | |||
| Deferred revenue | |||
| Net cash provided by (used in) operating activities | |||
| Cash flows from investing activities: | |||
| Purchases of investments | |||
| Sales and maturities of investments | |||
| Purchases of property and equipment | |||
| Net cash used in investing activities | |||
| Cash flows from financing activities: | |||
| Proceeds from public offerings, net of underwriting discounts and commissions | |||
| Payments of public offering costs | |||
| Proceeds from Securities Purchase Agreement | |||
| Proceeds from private placement, net of placement agent fees | |||
| Payments of private placement offering costs | |||
| Proceeds from initial public offering of common stock, net of underwriting discounts and commissions | |||
| Payments of initial public offering costs | |||
| Proceeds from option exercises | |||
| Proceeds from issuance of common stock under employee stock purchase plan | |||
| Net cash provided by financing activities | |||
| Net increase in cash, cash equivalents and restricted cash: | |||
| Cash, cash equivalents and restricted cash at beginning of period | |||
| Cash, cash equivalents and restricted cash at end of period | |||
| Supplemental disclosure of non-cash investing and financing activities: | |||
| Purchases of property and equipment included in accounts payable and accrued expenses | |||
| Issuance of common stock in connection with a former employee letter agreement | |||
| Issuance of common stock as settlement of contingent consideration liability | |||
| Accretion of redeemable convertible preferred stock to redemption value | |||
| Cash, cash equivalents and restricted cash at end of period: | |||
| Cash and cash equivalents | |||
| Restricted cash |
Loading...
